2026 Candidates Focus on Health Care Corruption in Campaigns

<p>In the lead-up to the midterm elections, candidates are increasingly emphasizing "corruption" in health care, moving beyond traditional discussions of coverage and costs. </p><p><strong>The big picture:</strong> Candidates are accusing their opponents of being influenced by drugmakers, insurers, and other powerful health interests, which they claim harms voters. </p><hr /><ul><li>This strategy aligns with public concerns about affordability and dissatisfaction with the health system, often neglecting specific issues that need addressing.</li><li>According to a survey by Lake Research Partners, voters are looking for leaders to reduce everyday costs and believe that tackling political corruption and corporate influence is essential.</li></ul><p><strong>Zoom in:</strong> This approach is evident in a competitive House race in Iowa's 1st Congressional District, where GOP Rep. Mariannette Miller-Meeks and Democrat Christina Bohannan have accused each other of being beholden to large health insurers and compromising patient care.</p><ul><li>In Michigan, Democratic Senate candidate Abdul El-Sayed labeled his Republican opponent Mike Rogers a "pharma lobbyist," which led to Rogers' campaign sending a cease-and-desist letter and threatening legal action.</li><li>Similar accusations regarding ties to health industries are appearing in key Senate races in New Hampshire and Nebraska.</li><li>Some democratic socialists have highlighted drug and insurer donations to incumbents during primary challenges, as seen when Melat Kiros defeated 15-term Rep. Diana DeGette in Colorado's 1st Congressional District.</li></ul><p><strong>Between the lines:</strong> Polling indicates that medical costs are the public's primary economic concern.</p><ul><li>Democratic challengers are leveraging this sentiment by focusing on their opponents' campaign contributions, while Republicans are emphasizing Democratic policies they argue benefit certain industries.</li><li>The Lake Research Partners survey found that voters attribute rising costs more to corporate greed and price gouging than to government spending.</li><li>According to the survey, voters are frustrated with perceived inequities in the system, believing that insiders and corporations have excessive power while ordinary citizens bear the costs.</li></ul><p><strong>Flashback:</strong> Last year, GOP lawmakers and conservative groups criticized the Affordable Care Act as a profit-making vehicle for health insurers while advocating for the expiration of pandemic-era enhanced subsidies.</p><ul><li>A recent NPR analysis of YouTube ads revealed that Republican candidates are attempting to preempt criticism regarding subsidy expirations and health spending cuts by focusing on fraud in Medicaid and affordability.</li><li>Democrats are aiming to hold Republicans accountable for health care cost issues, highlighting policies in the reconciliation bill that they argue negatively impacted millions.</li><li>Some Democrats are also criticizing former President Trump's drug pricing agreements, claiming they primarily benefited pharmaceutical companies.</li></ul><p><strong>What's next:</strong> House Democrats have pledged to reverse Medicaid cuts from the reconciliation bill and restore enhanced ACA subsidies, with an emphasis on increased oversight.</p><ul><li>Rep. Alexandria Ocasio-Cortez (D-N.Y.) stated the need for more action against corporate power and monopolies in health care, advocating for significant reforms.</li></ul><p><strong>What we're watching:</strong> It remains to be seen whether Republicans will heed Trump's advice to position insurance companies as adversaries in the final months before the midterms.</p><ul><li>Democrats will need to present a credible reform agenda beyond partisan attacks to address corruption and hold special interests accountable, according to Lake Research Partners.</li></ul>